Investors
Recent News
Coronavirus company news summary – BD receives additional orders for 177 million injection devices – AXIM develops Covid-19 test for neutralising antibodies
By Verdict Medical Devices Medical Marijuana has announced that its investment company AXIM Biotechnologies has developed a rapid diagnostic test that measures the levels of functional neutralising antibodies that are said to prevent SARS-CoV-2 (Covid-19) infection....
AXIM® Biotechnologies Welcomes Former Secretary of Veterans Affairs Peter O’Rourke to Company’s Board of Directors
SAN DIEGO, July 21, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM® Biotech," "AXIM" or "the Company"), an international healthcare solutions company targeting oncological and COVID-19 research, announced today it has welcomed Former...
First-in-Class COVID-19 Rapid Diagnostic Test for Neutralizing Antibodies Could Serve as Immunity Passport for Vaccine Developers
By LabMedica.com A new rapid diagnostic test for measuring levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells could serve as an ‘Immunity Passport’ for vaccine developers around the world as they begin...
Cannabis Stock Gainers And Losers From July 16, 2020
By Benzinga Axim Biotechnologies AXIM 2.36% shares closed up 34.82% at $0.97 Read the Full Article
AXIM Biotechnologies unveils rapid test for neutralizing antibodies, files Pre-EUA with the FDA
By Medical Laboratory Observer AXIM Biotechnologies, an healthcare solutions company focused on oncological research, has announced the development of NeuCovix, a rapid diagnostic test measuring levels of functional neutralizing antibodies that are believed to prevent...
First-in-Class COVID-19 Rapid Diagnostic Test for Neutralizing Antibodies Could Serve as Immunity Passport for Vaccine Developers
By HospiMedica International staff writers Posted on 16 Jul 2020 A new rapid diagnostic test for measuring levels of functional neutralizing antibodies that are believed to prevent SARS-CoV-2 from entering the host cells could serve as an ‘Immunity Passport’ for...
Email Alerts
Stay informed and receive company updates straight to your inbox
